Association mechanism of bicalutamide and human serum albumin for potential clinical implications

Yan Wang,Peng Liu,Jianzhong Zhang,Shuangshuang Wen
DOI: https://doi.org/10.1002/bio.4879
IF: 2.613
2024-09-04
Luminescence
Abstract:Bicalutamide bound to subdomain IB of HSA and interacted with HSA via the static quenching mechanism but had no obvious effect on the protein conformation of HSA. HSA exerts adaptive secondary and tertiary structural changes upon bicalutamide binding. The binding mechanism of molecular interaction between bicalutamide and human serum albumin (HSA) in a pH 7.4 phosphate buffer was studied using various spectroscopic techniques in combination with molecular modeling. Fluorescence data revealed that the fluorescence quenching of HSA by bicalutamide was a static quenching procedure. The binding constants and number of binding sites were evaluated at different temperatures. The thermodynamic parameters, ΔH and ΔS, were calculated to be 4.30 × 104 J·mol−1 and 245 J·mol−1·K−1, respectively, suggesting that the binding of bicalutamide to HSA was driven mainly by hydrophobic interactions and hydrogen bonds. The displacement studies indicated neither Sudlow's site I nor II but subdomain IB as the main binding site for bicalutamide on HSA. The binding distance between bicalutamide and HSA was determined to be 3.54 nm based on the Förster theory. Analysis of circular dichroism, synchronous, and 3D fluorescence spectra demonstrated that HSA conformation was slightly altered in the presence of bicalutamide.
chemistry, analytical
What problem does this paper attempt to address?